Latest Schedule 13D activist filings

Medalist Diversified REIT CEO Francis P. Kavanaugh disclosed additional share purchases and an exchange into OP Units, bringing beneficial ownership to 48.49% of the company.

5AM Ventures and affiliates disclosed selling 200,000 Entrada shares and updated beneficial ownership stakes ranging from 2.9% to 10.8%.

PharmaCyte Biotech reports 74.00% beneficial ownership of Q/C Technologies via preferred stock and warrants following shareholder approval.

PharmaCyte Biotech filed an amended Schedule 13D showing 74% beneficial ownership of Q/C Technologies via preferred stock, warrants, and recent $3M financing with anti-dilution protections.

Perceptive Advisors and its affiliates have reduced their beneficial ownership in Lyra Therapeutics, Inc. to 5.5% through recent share sales.

Blackwells Capital and its affiliates have increased their beneficial ownership in Braemar Hotels & Resorts Inc. to 5.8%, citing undervaluation and an attractive investment opportunity.

Glazer Capital, holding a 7.7% stake in Columbus Circle Capital Corp. I, has expressed opposition to the proposed business combination with ProCap BTC, citing concerns for public shareholders.

Rhea Marine Ltd. and Pankaj Khanna updated their beneficial ownership in Heidmar Maritime Holdings, collectively holding approximately 45% of outstanding shares, with a potential group ownership reaching nearly 90%.

Lynx1 Capital Management has withdrawn its $5.20 per share acquisition offer for Neuphoria Therapeutics, citing 'reckless' share issuances and significant shareholder dilution.

Joint Stock Company Kaspi.kz acquired an additional 10 million ordinary shares of D-MARKET Electronic Services & Trading for $29.5 million, increasing its beneficial ownership to 69.46%.

Joint Stock Company Kaspi.kz acquired an additional 10 million ordinary shares of D-MARKET Electronic Services & Trading for $29.5 million, increasing its beneficial ownership to 69.46%.

Haveli Group and related entities, including Brian N. Sheth, have increased their beneficial ownership in Blend Labs, Inc. to 20.9% of Class A common stock.

Fairmount Funds Management and its affiliates have reported a 19.99% beneficial ownership in Galecto, Inc. following the acquisition of Damora Therapeutics and a $285 million PIPE financing.

General Atlantic entities have filed an amended Schedule 13D, disclosing a plan to sell up to 3.5 million Centessa Pharmaceuticals ADSs.

An investor group led by MPM BioImpact and its affiliates reported open market sales of Werewolf Therapeutics common stock, reducing their collective beneficial ownership.

TotalEnergies announced the resignation of its two designated directors from the Clean Energy Fuels Corp. board, maintaining its 23.3% beneficial ownership.

TotalEnergies SE and its subsidiary updated their Schedule 13D filing for Clean Energy Fuels Corp., disclosing a 23.3% beneficial ownership stake and the resignation of two designated directors.

Veradace Partners, a significant Tiptree shareholder, has filed an amended Schedule 13D to detail its strong opposition to the proposed sale of Fortegra to DB Insurance, citing undervaluation and a flawed process.

An investor group led by American Industrial Partners Capital Fund VI, L.P. sold 2.25 million shares of V2X, Inc. common stock at $55.00 per share, leading to director resignations and a shift to passive investment.

BJ's Restaurants, Inc. and Act III Parties have amended their cooperation agreement, extending its term and revising standstill provisions regarding share acquisitions.

Two Seas Capital LP and affiliates increased their beneficial ownership in Core Scientific, Inc. to 8.0% through various stock and options transactions.

Blackstone and Finance of America Companies Inc. have amended their repurchase agreement, introducing a two-stage closing, price escalations for delays, and new termination rights for Blackstone.

Alexandra Seros, trustee of trusts holding significant Entravision Communications stock, has sold 353,068 shares and plans to sell up to 500,000 more for diversification and estate planning.

Eric Sprott and affiliated entities' beneficial ownership in New Found Gold Corp. decreased to 19.42% following the Maritime Resources acquisition, despite receiving additional shares.

River Road Asset Management, LLC has disclosed a 6.1% beneficial ownership stake in UniFirst Corp, acquired for investment purposes using client funds totaling over $134 million.

Oaktree Capital Management has filed an amendment to its Schedule 13D for TORM plc, updating its beneficial ownership percentage to 40.05% due to a change in the issuer's outstanding Class A shares.

William W. Smith, Jr., CEO of Smith Micro Software, Inc., increased his beneficial ownership to 30.0% through recent share and warrant acquisitions by the Smith Living Trust.

BW Group Limited has reduced its beneficial ownership in DHT Holdings to 10.57% through a series of open market share sales.

Samsara BioCapital and related entities have reduced their beneficial ownership in Alumis Inc. to below 5% through recent share sales and transfers.

Merck Sharp & Dohme LLC's subsidiary, Caymus Purchaser, Inc., will launch a cash tender offer to acquire Cidara Therapeutics, Inc. for $221.50 per common share and $15,505.00 per Series A preferred share.